Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Radiotherapy; Chemotherapy Interventions: Radiation: reduced dosage IMRT; Radiation: conventional dosage IMRT Sponsors: Sun Yat-sen University; National Cancer Centre, Singapore; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; Zhongshan People's Hospital, Guangdong, China; Yuebei People's Hospital; Wuzhou Red Cross Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | China Health | Hospitals | Intensity-Modulated Radiation Therapy | Nasopharyngeal Cancer | Research | Singapore Health